Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Papillomavirus Infections 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 2treosulfan 1defactinib 1decitabine and cedazuridine drug combination 1cedazuridine 1cc-486 1Human Papillomavirus Recombinant Vaccine nonavalent 1Decitabine 1Busulfan 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Myelodysplastic Syndromes × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT06793410 2025-06-05

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Vastra Gotaland Region

Phase 2 Recruiting
100 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡